Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Clinical trial NCT02559024 · TERMINATED

Trial details

NCT number: NCT02559024
Sponsor: Providence Health & Services
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2016-03-14
Primary completion: 2018-10-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.